Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Current Taxes (2023 - 2025)

Historic Current Taxes for Catalyst Pharmaceuticals (CPRX) over the last 3 years, with Q3 2025 value amounting to $710000.0.

  • Catalyst Pharmaceuticals' Current Taxes changed N/A to $710000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $710000.0, marking a year-over-year change of. This contributed to the annual value of $894000.0 for FY2024, which is 2263.37% up from last year.
  • Catalyst Pharmaceuticals' Current Taxes amounted to $710000.0 in Q3 2025.
  • In the past 5 years, Catalyst Pharmaceuticals' Current Taxes ranged from a high of $11.1 million in Q1 2025 and a low of $15000.0 during Q2 2024
  • Its 3-year average for Current Taxes is $2.3 million, with a median of $719500.0 in 2023.
  • Its Current Taxes has fluctuated over the past 5 years, first skyrocketed by 2263.37% in 2024, then soared by 282666.67% in 2025.
  • Catalyst Pharmaceuticals' Current Taxes (Quarter) stood at $729000.0 in 2023, then increased by 22.63% to $894000.0 in 2024, then decreased by 20.58% to $710000.0 in 2025.
  • Its Current Taxes was $710000.0 in Q3 2025, compared to $439000.0 in Q2 2025 and $11.1 million in Q1 2025.